Article

Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions

2020-05-20

Abstract excerpt

<title>Abstract</title> <p>Background The purpose of this study was to study the relationship between <italic>ALK&ROS1</italic> gene rearrangement, <italic>EGFR</italic> mutation, non-<italic>ALK&ROS1/EGFR</italic> and their clinical characteristics in non-small cell lung cancer (NSCLC) patients to distinguish these different types. Methods Both <italic>ALK&ROS1</italic> gene rearrangements and <italic>EGFR</it...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b0578822-6f6e-5473-8e36-5d86fbac9d6a
DOI: 10.21203/rs.3.rs-29254/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusionsDOI 10.21203/rs.3.rs-29254/v1Read

Clinical characteristics of non-small cell lung cancer patients with EGFR mutations and ALK&ROS1 fusions.Semantic proximity Read

[Clinicopathological significance in non-small cell lung cancer with mutations and co-mutations of EGFR, ALK and ROS1].Semantic proximity Read

Progress of non-small-cell lung cancer with ROS1 rearrangementSemantic proximity Read

[Clinical features of 54 cases of lung adenocarcinomas with c-ROS oncogene 1 fusion].Semantic proximity Read

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to DateSemantic proximity Read

Evaluation of ROS1 expression and rearrangements in a large cohort of early- stage lung cancerSemantic proximity Read

Survival of Patients with Advanced Non-Small Cell Lung Cancer Harboring Different ROS1 Fusion Subtypes: A Real-World StudySemantic proximity Read

Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations.Semantic proximity Read

Concurrent EGFR L858R and K860I mutations: PCR-negative but NGS-positive alterations that respond to EGFR inhibitors in non-small cell lung cancerSemantic proximity Read

ALK, ROS1 and EGFR status of lung cancers in the Aegean Region of Turkey.Semantic proximity Read

A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patientsSemantic proximity Read

Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patients.Semantic proximity Read